Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1986 Oct;78(4):1112–1119. doi: 10.1172/JCI112668

von Willebrand protein facilitates platelet incorporation in polymerizing fibrin.

J Loscalzo, A Inbal, R I Handin
PMCID: PMC423774  PMID: 3489737

Abstract

von Willebrand protein was found to promote the incorporation of platelets into evolving fibrin thrombi. Using formalin-treated or fresh platelets, both the initial rate and extent of platelet incorporation into polymerizing fibrin were dependent on von Willebrand protein. von Willebrand protein was incorporated into evolving fibrin thrombi in parallel with platelets. Soluble fibrin monomer covalently linked to acrylonitrile beads (Matrex 102) bound von Willebrand protein specifically and saturably with an apparent approximate dissociation constant (KD) of 15 micrograms/ml. Glycocalicin, the water-soluble proteolytic fragment of glycoprotein Ib, bound to fibrin monomer in this system specifically and saturably, as well, with an apparent approximate KD of 5 micrograms/ml, but only in the presence of saturating concentrations of von Willebrand protein. These data demonstrate that the initial rate and extent of platelet incorporation into evolving fibrin thrombi are dependent on von Willebrand protein; von Willebrand protein serves as a link between polymerizing fibrin and platelet surface glycoprotein Ib; and von Willebrand protein binds to fibrin monomer and is thereby able to bind to platelet surface glycoprotein Ib in the absence of ristocetin.

Full text

PDF
1112

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adelman B., Michelson A. D., Loscalzo J., Greenberg J., Handin R. I. Plasmin effect on platelet glycoprotein Ib-von Willebrand factor interactions. Blood. 1985 Jan;65(1):32–40. [PubMed] [Google Scholar]
  2. Allain J. P., Cooper H. A., Wagner R. H., Brinkhous K. M. Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor. J Lab Clin Med. 1975 Feb;85(2):318–328. [PubMed] [Google Scholar]
  3. BORN G. V., CROSS M. J. THE AGGREGATION OF BLOOD PLATELETS. J Physiol. 1963 Aug;168:178–195. doi: 10.1113/jphysiol.1963.sp007185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Baumgartner H. R. Platelet interaction with collagen fibrils in flowing blood. I. Reaction of human platelets with alpha chymotrypsin-digested subendothelium. Thromb Haemost. 1977 Feb 28;37(1):1–16. [PubMed] [Google Scholar]
  5. Baumgartner H. R., Tschopp T. B., Weiss H. J. Platelet interaction with collagen fibrils in flowing blood. II. Impaired adhesion-aggregation in bleeding disorders. A comparison with subendothelium. Thromb Haemost. 1977 Feb 28;37(1):17–28. [PubMed] [Google Scholar]
  6. Booyse F. M., Feder S., Quarfoot A. J. Culture-produced subendothelium. II. Effect of plasma, F.VIIIR:WF and fibronectin on interaction of normal platelets with normal and von Willebrand porcine aortic subendothelium. Thromb Res. 1982 Nov 1;28(3):299–311. doi: 10.1016/0049-3848(82)90113-x. [DOI] [PubMed] [Google Scholar]
  7. Brinkhous K. M., Read M. S. Preservation of platelet receptors for platelet aggregating factor/von Willebrand factor by air drying, freezing, or lyophilization: new stable platelet preparations for von Willebrand factor assays. Thromb Res. 1978 Oct;13(4):591–597. doi: 10.1016/0049-3848(78)90148-2. [DOI] [PubMed] [Google Scholar]
  8. Brosstad F., Rygh M., Kierulf P., Godal H. C., Eika C. Interaction of platelets with soluble, polymerizing and polymerized des-AA and des-AABB fibrin in human plasma. Thromb Res. 1980 Apr 1;18(1-2):123–130. doi: 10.1016/0049-3848(80)90176-0. [DOI] [PubMed] [Google Scholar]
  9. Brown R. S., Niewiarowski S., Stewart G. J., Millman M. A double-isotope study on incorporation of platelets and red cells into fibrin. J Lab Clin Med. 1977 Jul;90(1):130–140. [PubMed] [Google Scholar]
  10. Coller B. S. Interaction of normal, thrombasthenic, and Bernard-Soulier platelets with immobilized fibrinogen: defective platelet-fibrinogen interaction in thrombasthenia. Blood. 1980 Feb;55(2):169–178. [PubMed] [Google Scholar]
  11. Coller B. S., Peerschke E. I., Scudder L. E., Sullivan C. A. Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood. 1983 Jan;61(1):99–110. [PubMed] [Google Scholar]
  12. Day H. J., Solum N. O. Fibrinogen associated with subcellular platelet particles. Scand J Haematol. 1973;10(2):136–143. doi: 10.1111/j.1600-0609.1973.tb00050.x. [DOI] [PubMed] [Google Scholar]
  13. Fujimoto T., Hawiger J. Adenosine diphosphate induces binding of von Willebrand factor to human platelets. Nature. 1982 May 13;297(5862):154–156. doi: 10.1038/297154a0. [DOI] [PubMed] [Google Scholar]
  14. Fujimoto T., Ohara S., Hawiger J. Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets. J Clin Invest. 1982 Jun;69(6):1212–1222. doi: 10.1172/JCI110560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Giddings J. C., Shearn S. A., Bloom A. L. Platelet-associated coagulation factors: immunological detection and the effect of calcium. Br J Haematol. 1978 Aug;39(4):569–577. doi: 10.1111/j.1365-2141.1978.tb03627.x. [DOI] [PubMed] [Google Scholar]
  16. Gralnick H. R., Williams S. B., Coller B. S. Fibrinogen competes with von Willebrand factor for binding to the glycoprotein IIb/IIIa complex when platelets are stimulated with thrombin. Blood. 1984 Oct;64(4):797–800. [PubMed] [Google Scholar]
  17. Hantgan R. R., Taylor R. G., Lewis J. C. Platelets interact with fibrin only after activation. Blood. 1985 Jun;65(6):1299–1311. [PubMed] [Google Scholar]
  18. Houdijk W. P., Sakariassen K. S., Nievelstein P. F., Sixma J. J. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III. J Clin Invest. 1985 Feb;75(2):531–540. doi: 10.1172/JCI111729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hovig T., Jorgensen L., Packham M. A., Mustard J. F. Platelet adherence to fibrin and collagen. J Lab Clin Med. 1968 Jan;71(1):29–40. [PubMed] [Google Scholar]
  20. Kettner C., Shaw E. D-Phe-Pro-ArgCH2C1-A selective affinity label for thrombin. Thromb Res. 1979;14(6):969–973. doi: 10.1016/0049-3848(79)90014-8. [DOI] [PubMed] [Google Scholar]
  21. LATALLO Z. S., FLETCHER A. P., ALKJAERSIG N., SHERRY S. Influence of pH, ionic strength, neutral ions, and thrombin on fibrin polymerization. Am J Physiol. 1962 Apr;202:675–680. doi: 10.1152/ajplegacy.1962.202.4.675. [DOI] [PubMed] [Google Scholar]
  22. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  23. Laudano A. P., Doolittle R. F. Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species differences. Biochemistry. 1980 Mar 4;19(5):1013–1019. doi: 10.1021/bi00546a028. [DOI] [PubMed] [Google Scholar]
  24. Legrand Y. J., Rodriguez-Zeballos A., Kartalis G., Fauvel F., Caen J. P. Adsorption of factor VIII antigen-activity complex by collagen. Thromb Res. 1978 Nov;13(5):909–911. doi: 10.1016/0049-3848(78)90196-2. [DOI] [PubMed] [Google Scholar]
  25. Leytin V. L., Gorbunova N. A., Misselwitz F., Novikov I. D., Podrez E. A., Plyusch O. P., Likhachova E. A., Repin V. S., Smirnov V. N. Step-by-step analysis of adhesion of human platelets to a collagen-coated surface defect in initial attachment and spreading of platelets in von Willebrand's disease. Thromb Res. 1984 Apr 1;34(1):51–63. doi: 10.1016/0049-3848(84)90105-1. [DOI] [PubMed] [Google Scholar]
  26. Loscalzo J., Handin R. I. Conformational domains and structural transitions of human von Willebrand protein. Biochemistry. 1984 Aug 14;23(17):3880–3886. doi: 10.1021/bi00312a014. [DOI] [PubMed] [Google Scholar]
  27. Loscalzo J., Slayter H., Handin R. I., Farber D. Subunit structure and assembly of von Willebrand factor polymer: complementary analysis by electron microscopy and quasielastic light scattering. Biophys J. 1986 Jan;49(1):49–50. doi: 10.1016/S0006-3495(86)83588-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Marcus A. J. The role of lipids in platelet function: with particular reference to the arachidonic acid pathway. J Lipid Res. 1978 Sep;19(7):793–826. [PubMed] [Google Scholar]
  29. Marcus A. J., Zucker-Franklin D., Safier L. B., Ullman H. L. Studies on human platelet granules and membranes. J Clin Invest. 1966 Jan;45(1):14–28. doi: 10.1172/JCI105318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Marguerie G. A., Edgington T. S., Plow E. F. Interaction of fibrinogen with its platelet receptor as part of a multistep reaction in ADP-induced platelet aggregation. J Biol Chem. 1980 Jan 10;255(1):154–161. [PubMed] [Google Scholar]
  31. Marguerie G. A., Thomas-Maison N., Larrieu M. J., Plow E. F. The interaction of fibrinogen with human platelets in a plasma milieu. Blood. 1982 Jan;59(1):91–95. [PubMed] [Google Scholar]
  32. Michelson A. D., Loscalzo J., Melnick B., Coller B. S., Handin R. I. Partial characterization of a binding site for von Willebrand factor on glycocalicin. Blood. 1986 Jan;67(1):19–26. [PubMed] [Google Scholar]
  33. Mustard J. F., Packham M. A., Kinlough-Rathbone R. L., Perry D. W., Regoeczi E. Fibrinogen and ADP-induced platelet aggregation. Blood. 1978 Aug;52(2):453–466. [PubMed] [Google Scholar]
  34. Nachman R. L., Hubbard A., Ferris B. Iodination of the human platelet membrane. Studies of the major surface glycoprotein. J Biol Chem. 1973 Apr 25;248(8):2928–2936. [PubMed] [Google Scholar]
  35. Niewiarowski S., Regoeczi E., Stewart G. J., Senyl A. F., Mustard J. F. Platelet interaction with polymerizing fibrin. J Clin Invest. 1972 Mar;51(3):685–699. doi: 10.1172/JCI106857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Niewiarowski S., Stewart G. J., Nath N., Sha A. T., Lieberman G. E. ADP, thrombin, and Bothrops atrox thrombinlike enzyme in platelet-dependent fibrin retraction. Am J Physiol. 1975 Sep;229(3):737–745. doi: 10.1152/ajplegacy.1975.229.3.737. [DOI] [PubMed] [Google Scholar]
  37. Olson J. D., Brockway W. J., Fass D. N., Magnuson M. A., Bowie E. J. Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet aggregation. Am J Clin Pathol. 1975 Feb;63(2):210–218. doi: 10.1093/ajcp/63.2.210. [DOI] [PubMed] [Google Scholar]
  38. Phillips D. R. Effect of trypsin on the exposed polypeptides and glycoproteins in the human platelet membrane. Biochemistry. 1972 Nov 21;11(24):4582–4588. doi: 10.1021/bi00774a025. [DOI] [PubMed] [Google Scholar]
  39. Rosborough T. K. Von Willebrand factor, polycations, and platelet agglutination. Thromb Res. 1980 Feb 1;17(3-4):481–490. doi: 10.1016/0049-3848(80)90083-3. [DOI] [PubMed] [Google Scholar]
  40. Ruggeri Z. M., De Marco L., Gatti L., Bader R., Montgomery R. R. Platelets have more than one binding site for von Willebrand factor. J Clin Invest. 1983 Jul;72(1):1–12. doi: 10.1172/JCI110946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Ruggeri Z. M., Zimmerman T. S. The complex multimeric composition of factor VIII/von Willebrand factor. Blood. 1981 Jun;57(6):1140–1143. [PubMed] [Google Scholar]
  42. Ruggeri Z. M., Zimmerman T. S. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets. J Clin Invest. 1980 Jun;65(6):1318–1325. doi: 10.1172/JCI109795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Sakariassen K. S., Bolhuis P. A., Sixma J. J. Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium. Nature. 1979 Jun 14;279(5714):636–638. doi: 10.1038/279636a0. [DOI] [PubMed] [Google Scholar]
  44. Santoro S. A. Adsorption of von Willebrand factor/factor VIII by the genetically distinct interstitial collagens. Thromb Res. 1981 Mar 15;21(6):689–691. doi: 10.1016/0049-3848(81)90272-3. [DOI] [PubMed] [Google Scholar]
  45. Schafer A. I., Adelman B. Plasmin inhibition of platelet function and of arachidonic acid metabolism. J Clin Invest. 1985 Feb;75(2):456–461. doi: 10.1172/JCI111720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Schick P. K. The role of platelet membrane lipids in platelet hemostatic activities. Semin Hematol. 1979 Jul;16(3):221–233. [PubMed] [Google Scholar]
  47. Schullek J., Jordan J., Montgomery R. R. Interaction of von Willebrand factor with human platelets in the plasma milieu. J Clin Invest. 1984 Feb;73(2):421–428. doi: 10.1172/JCI111228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Slayter H., Loscalzo J., Bockenstedt P., Handin R. I. Native conformation of human von Willebrand protein. Analysis by electron microscopy and quasi-elastic light scattering. J Biol Chem. 1985 Jul 15;260(14):8559–8563. [PubMed] [Google Scholar]
  49. Slot J. W., Bouma B. N., Montgomery R., Zimmerman T. S. Platelet factor VIII-related antigen: immunofluorescent localization. Thromb Res. 1978 Nov;13(5):871–881. doi: 10.1016/0049-3848(78)90192-5. [DOI] [PubMed] [Google Scholar]
  50. Solum N. O., Hagen I., Peterka M., Gjemdal T. Absence of the 145,000 molecular weight, soluble platelet membrane glycoprotein--lack of platelet agglutination. Thromb Haemost. 1980 Feb 29;42(5):1626–1629. [PubMed] [Google Scholar]
  51. Tangen O., Wik O. K., Berman H. J. The effect of thrombin, reptilase, and a fibrinopeptide B-releasing enzyme from the venom of the southern copperhead snake on rabbit platelets. Microvasc Res. 1973 Nov;6(3):342–346. doi: 10.1016/0026-2862(73)90082-4. [DOI] [PubMed] [Google Scholar]
  52. Tschopp T. B., Weiss H. J., Baumgartner H. R. Decreased adhesion of platelets to subendothelium in von Willebrand's disease. J Lab Clin Med. 1974 Feb;83(2):296–300. [PubMed] [Google Scholar]
  53. Turitto V. T., Weiss H. J., Baumgartner H. R. Platelet interaction with rabbit subendothelium in von Willebrand's disease: altered thrombus formation distinct from defective platelet adhesion. J Clin Invest. 1984 Nov;74(5):1730–1741. doi: 10.1172/JCI111591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Weiss H. J., Baumgartner H. R., Tschopp T. B., Turitto V. T., Cohen D. Correction by factor VIII of the impaired platelet adhesion to subendothelium in von Willebrand disease. Blood. 1978 Feb;51(2):267–279. [PubMed] [Google Scholar]
  55. Weiss H. J., Rogers J. Fibrinogen and platelets in the primary arrest of bleeding. Studies in two patients with congenital afibrinogenemia. N Engl J Med. 1971 Aug 12;285(7):369–374. doi: 10.1056/NEJM197108122850703. [DOI] [PubMed] [Google Scholar]
  56. Weiss H. J., Tschopp T. B., Baumgartner H. R., Sussman I. I., Johnson M. M., Egan J. J. Decreased adhesion of giant (Bernard-Soulier) platelets to subendothelium. Further implications on the role of the von Willebrand factor in hemostasis. Am J Med. 1974 Dec;57(6):920–925. doi: 10.1016/0002-9343(74)90170-3. [DOI] [PubMed] [Google Scholar]
  57. Zucker M. B., Broekman M. J., Kaplan K. L. Factor VIII-related antigen in human blood platelets: localization and release by thrombin and collagen. J Lab Clin Med. 1979 Nov;94(5):675–682. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES